T.R. Leyshon Griffiths

3.3k total citations
67 papers, 2.3k citations indexed

About

T.R. Leyshon Griffiths is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, T.R. Leyshon Griffiths has authored 67 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Surgery, 16 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in T.R. Leyshon Griffiths's work include Bladder and Urothelial Cancer Treatments (37 papers), Urinary and Genital Oncology Studies (22 papers) and Urological Disorders and Treatments (9 papers). T.R. Leyshon Griffiths is often cited by papers focused on Bladder and Urothelial Cancer Treatments (37 papers), Urinary and Genital Oncology Studies (22 papers) and Urological Disorders and Treatments (9 papers). T.R. Leyshon Griffiths collaborates with scholars based in United Kingdom, United States and Sweden. T.R. Leyshon Griffiths's co-authors include David E. Neal, Marina Kriajevska, Luke Vale, James N’Dow, G Mowatt, Charles Boachie, J.K. Mellon, Ghulam Nabi, Jonathan Cook and J. Kilian Mellon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Cochrane Database of Systematic Reviews.

In The Last Decade

T.R. Leyshon Griffiths

67 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T.R. Leyshon Griffiths United Kingdom 25 1.2k 850 705 474 297 67 2.3k
Bernd J. Schmitz‐Dräger Germany 26 1.7k 1.4× 1.1k 1.2× 488 0.7× 501 1.1× 344 1.2× 114 2.7k
S. Larré France 23 1.0k 0.8× 559 0.7× 547 0.8× 298 0.6× 334 1.1× 125 1.9k
Yoshiyuki Matsui Japan 27 1.0k 0.8× 679 0.8× 733 1.0× 444 0.9× 630 2.1× 178 2.6k
Ho Kyung Seo South Korea 22 1.1k 0.9× 500 0.6× 749 1.1× 515 1.1× 316 1.1× 148 2.1k
Lorenzo Masieri Italy 25 746 0.6× 777 0.9× 1.0k 1.5× 500 1.1× 508 1.7× 124 2.3k
Murugesan Manoharan United States 30 1.9k 1.5× 643 0.8× 1.3k 1.8× 515 1.1× 682 2.3× 119 3.3k
Satoshi Anai Japan 31 783 0.6× 959 1.1× 924 1.3× 741 1.6× 175 0.6× 164 2.8k
Shingo Hatakeyama Japan 22 664 0.5× 542 0.6× 523 0.7× 264 0.6× 282 0.9× 176 1.8k
Tatsuya Takayama Japan 26 651 0.5× 593 0.7× 752 1.1× 450 0.9× 82 0.3× 128 2.0k
Toshihiko Kotake Japan 23 700 0.6× 619 0.7× 532 0.8× 344 0.7× 159 0.5× 87 1.8k

Countries citing papers authored by T.R. Leyshon Griffiths

Since Specialization
Citations

This map shows the geographic impact of T.R. Leyshon Griffiths's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.R. Leyshon Griffiths with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.R. Leyshon Griffiths more than expected).

Fields of papers citing papers by T.R. Leyshon Griffiths

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.R. Leyshon Griffiths. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.R. Leyshon Griffiths. The network helps show where T.R. Leyshon Griffiths may publish in the future.

Co-authorship network of co-authors of T.R. Leyshon Griffiths

This figure shows the co-authorship network connecting the top 25 collaborators of T.R. Leyshon Griffiths. A scholar is included among the top collaborators of T.R. Leyshon Griffiths based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.R. Leyshon Griffiths. T.R. Leyshon Griffiths is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mayer, Nick, et al.. (2015). Is Immediate Radical Cystectomy Necessary for All Patients with Non-Muscle-Invasive Micropapillary Bladder Cancer?. Urologia Internationalis. 96(1). 32–38. 10 indexed citations
3.
MacLennan, Steven, Mari Imamura, Marie Carmela Lapitan, et al.. (2012). Systematic Review of Perioperative and Quality-of-life Outcomes Following Surgical Management of Localised Renal Cancer. European Urology. 62(6). 1097–1117. 186 indexed citations
4.
MacLennan, Sara, Steven MacLennan, Mari Imamura, et al.. (2011). Urological cancer care pathways: development and use in the context of systematic reviews and clinical practice guidelines. World Journal of Urology. 29(3). 291–301. 16 indexed citations
5.
6.
Mellon, J. Kilian, et al.. (2010). Management of the Distal Ureter during Nephroureterectomy for Upper Urinary Tract Transitional Cell Carcinoma: A Review. Urologia Internationalis. 85(3). 249–256. 16 indexed citations
7.
Ayres, Benjamin, T.R. Leyshon Griffiths, Hugh Mostafid, et al.. (2010). The role of hexylaminolaevulinate in the diagnosis and follow‐up of non‐muscle‐invasive bladder cancer. British Journal of Urology. 105(s2). 2–7. 9 indexed citations
8.
Tarabykina, Svetlana, T.R. Leyshon Griffiths, Eugene Tulchinsky, et al.. (2007). Metastasis-Associated Protein S100A4: Spotlight on its Role in Cell Migration. Current Cancer Drug Targets. 7(3). 217–228. 91 indexed citations
9.
Bodiwala, Dhaval, Santhini Jeyarajah, Tim Terry, & T.R. Leyshon Griffiths. (2007). THE FIRST SEMEN ANALYSIS AFTER VASECTOMY: TIMING AND DEFINITION OF SUCCESS. British Journal of Urology. 99(4). 727–728. 7 indexed citations
10.
Colquhoun, Alexandra, Santhanam Sundar, P. Rajjayabun, et al.. (2006). Epidermal Growth Factor Receptor Status Predicts Local Response to Radical Radiotherapy in Muscle-invasive Bladder Cancer. Clinical Oncology. 18(9). 702–709. 12 indexed citations
11.
12.
Sharma, Ricky A., et al.. (2004). Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies. European Journal of Cancer. 41(1). 61–70. 103 indexed citations
13.
Heer, Rakesh, et al.. (2004). A Prospective Audit of Hypospadias Correction in a Regional Paediatric Surgery Centre. European Journal of Pediatric Surgery. 14(5). 328–332. 2 indexed citations
14.
Skolarikos, Andreas, et al.. (2003). Cytologic analysis of ureteral washings is informative in patients with grade 2 upper tract TCC considering endoscopic treatment. Urology. 61(6). 1146–1150. 55 indexed citations
15.
Griffiths, T.R. Leyshon, Mary E. Charlton, David E. Neal, & Philip Powell. (2003). Treatment of carcinoma in situ with intravesical bacillus calmette-guerin without maintenance.. Urologic Oncology Seminars and Original Investigations. 21(2). 169–169. 17 indexed citations
16.
Griffiths, T.R. Leyshon & J. Kilian Mellon. (2000). Human papillomavirus and urological tumours: II. Role in bladder, prostate, renal and testicular cancer. British Journal of Urology. 85(2). 211–217. 28 indexed citations
17.
Griffiths, T.R. Leyshon, et al.. (1998). Chemotherapy and muscle-invasive bladder cancer: Assessment of p53 immuno-reactivity (IR) as a predictor of response. British Journal of Cancer. 78. 20–20. 1 indexed citations
18.
Griffiths, T.R. Leyshon, I. Brotherick, C. H. W. Horne, et al.. (1996). Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence. British Journal of Cancer. 74(4). 579–584. 78 indexed citations
19.
Griffiths, T.R. Leyshon, et al.. (1995). P53 and ploidy assessed by flow cytometry in bladder washings. British Journal of Urology. 76(5). 575–579. 6 indexed citations
20.
Priestman, T.J., et al.. (1988). Randomized Trial Comparing Aminoglutethimide With High-Dose Medroxyprogesterone Acetate in Therapy for Advanced Breast Carcinomau. JNCI Journal of the National Cancer Institute. 80(14). 1147–1151. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernd J. Schmitz‐Dräger Breakdown of academic impact, for papers by S. Larré Breakdown of academic impact, for papers by Yoshiyuki Matsui Breakdown of academic impact, for papers by Ho Kyung Seo Breakdown of academic impact, for papers by Lorenzo Masieri Breakdown of academic impact, for papers by Murugesan Manoharan Breakdown of academic impact, for papers by Satoshi Anai Breakdown of academic impact, for papers by Shingo Hatakeyama Breakdown of academic impact, for papers by Tatsuya Takayama Breakdown of academic impact, for papers by Toshihiko Kotake
Rankless by CCL
2026